Mutation of residues in the C3dg region of human complement component C3 corresponding to a proposed binding site for complement receptor type 2 (CR2, CD21) does not abolish binding of iC3b or C3dg to CR2.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples